MENU
+Compare
HTSUF
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$29.00
Change
-$0.00 (-0.00%)
Capitalization
2.84B

HTSUF Hisamitsu Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products... Show more

HTSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HTSUF with price predictions
Jan 13, 2026

HTSUF sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for HTSUF moved below the 200-day moving average on December 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HTSUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HTSUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.186) is normal, around the industry mean (29.656). P/E Ratio (16.712) is within average values for comparable stocks, (75.571). HTSUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.019). Dividend Yield (0.020) settles around the average of (0.030) among similar stocks. P/S Ratio (2.110) is also within normal values, averaging (72.365).

View a ticker or compare two or three
HTSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

HTSUF paid dividends on November 05, 2020

Hisamitsu Pharmaceutical Co., Ltd. HTSUF Stock Dividends
А dividend of $41.75 per share was paid with a record date of November 05, 2020, and an ex-dividend date of August 28, 2020. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
408 Tashiro Daikan-machi
Phone
+81 942832101
Employees
3428
Web
http://www.hisamitsu.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSCZX17.820.11
+0.62%
JPMorgan US Small Company R2
APHGX28.970.04
+0.14%
Artisan Global Value Institutional
BSVIX15.25-0.02
-0.13%
Baird Equity Opportunity Institutional
FMPFX40.09-0.17
-0.42%
Nuveen Small Cap Growth Opp R6
SCMIX206.27-3.06
-1.46%
Columbia Seligman Tech & Info Inst2

HTSUF and Stocks

Correlation & Price change

A.I.dvisor tells us that HTSUF and ORGO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUF and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
ORGO - HTSUF
26%
Poorly correlated
-3.55%
PHCUF - HTSUF
26%
Poorly correlated
N/A
HYPMY - HTSUF
3%
Poorly correlated
-3.41%
IPSEY - HTSUF
3%
Poorly correlated
N/A
HLTRF - HTSUF
1%
Poorly correlated
N/A
More

Groups containing HTSUF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUF
1D Price
Change %
HTSUF100%
N/A
Pharmaceuticals: Generic
industry (218 stocks)
9%
Poorly correlated
+0.27%